SPOTLIGHT -
Roflumilast Cream Meets Endpoint in Study of Young Children with Atopic Dermatitis
In addition, a supplemental new drug application has been filed for roflumilast cream .15% to treat mild-to-moderate atopic dermatitis in adults and children aged 6 years and older.
Read More